Loading...
•
Sep 30, 2021
Health Catalyst Q3 2021 Earnings Report
Achieved strong performance exceeding quarterly guidance for revenue and Adjusted EBITDA.
Key Takeaways
Health Catalyst reported strong third-quarter results, exceeding the midpoint of their quarterly guidance for both revenue and Adjusted EBITDA. The company also hosted its annual Healthcare Analytics Summit conference in September, with over 3,000 registrants.
Total revenue for the quarter was $61.737 million, a 31% increase year-over-year.
Technology revenue was $38.262 million, a 37% increase year-over-year.
Professional services revenue was $23.475 million, a 22% increase year-over-year.
Adjusted EBITDA was $(5.794) million, compared to $(6.434) million in the same quarter last year.
Revenue by Segment
Forward Guidance
For the fourth quarter of 2021, Health Catalyst expects total revenue between $61.4 million and $64.4 million, and Adjusted EBITDA between $(7.5) million and $(5.5) million. For the full year of 2021, the company expects total revenue between $238.6 million and $241.6 million, and Adjusted EBITDA between $(12.5) million and $(10.5) million.
Positive Outlook
- Total revenue between $61.4 million and $64.4 million for Q4 2021
- Adjusted EBITDA between $(7.5) million and $(5.5) million for Q4 2021
- Total revenue between $238.6 million and $241.6 million for the full year 2021
- Adjusted EBITDA between $(12.5) million and $(10.5) million for the full year 2021
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...